Immunome (IMNM)
(Delayed Data from NSDQ)
$13.95 USD
+0.45 (3.33%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $14.00 +0.05 (0.36%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.56 |
EPS Last Quarter | -0.49 |
Last EPS Surprise | -28.95% |
ABR | 1.00 |
Earnings ESP
|
-7.65% |
---|---|
Current Year | -4.02 |
Next Year | -2.83 |
EPS (TTM) | -1.73 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.93M | 4.43M | 6.64M | 4.22M |
# of Estimates | 2 | 2 | 4 | 1 |
High Estimate | 4.80M | 7.80M | 16.00M | 4.22M |
Low Estimate | 1.05M | 1.06M | 3.00M | 4.22M |
Year ago Sales | 3.57M | 3.83M | 14.02M | 6.64M |
Year over Year Growth Est. | -18.07% | 15.67% | -52.62% | -36.46% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.56 | -0.61 | -4.02 | -2.83 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | -0.64 | -0.67 | -4.19 | -3.30 |
High Estimate | -0.39 | -0.50 | -3.58 | -2.17 |
Low Estimate | -0.77 | -0.81 | -4.51 | -3.97 |
Year ago EPS | -0.36 | -0.54 | -1.31 | -4.02 |
Year over Year Growth Est. | -55.56% | -12.96% | -206.87% | 29.60% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 3 | 3 | 3 | 2 |
Down Last 30 Days | 3 | 3 | 3 | 2 |
Down Last 60 Days | 3 | 3 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.56 | -0.61 | -4.02 | -2.83 |
7 Days Ago | -0.42 | -0.47 | -3.66 | -2.72 |
30 Days Ago | -0.42 | -0.47 | -3.66 | -2.72 |
60 Days Ago | -0.42 | -0.47 | -3.66 | -2.72 |
90 Days Ago | -0.41 | -0.48 | -3.64 | -2.89 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.61 | -0.63 | -4.23 | -3.27 |
Zacks Consensus Estimate | -0.56 | -0.61 | -4.02 | -2.83 |
Earnings ESP | -7.65% | -2.86% | -5.12% | -15.27% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.49 | -0.34 | -0.54 | -0.36 | NA |
Estimate | -0.38 | -0.80 | -0.28 | NA | NA |
Difference | -0.11 | 0.46 | -0.26 | NA | 0.03 |
Surprise | -28.95% | 57.50% | -92.86% | NA | -21.44% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more